10 - 14 days
Update Type: Test Down or Delayed
Test Updated: 09/04/2019
Antineuronal Nuclear Antibodies
Dorsal Root Ganglion Antibody
Neuronal Nuclear Antibody, Type 1
Neuronal Nuclear Antibody, Type 2
Neuronal Nuclear Antibody, Type 3
Paraneoplastic Cerebellar Degeneration (PCD)
Purkinje Cell Cytoplasmic Antibody, Type 1
Purkinje Cell Cytoplasmic Antibody, Type 2
Purkinje Cell Cytoplasmic Antibody, Type Tr
ACh Receptor (Muscle) Binding Antibody
P/Q Type Calcium Channel Antibody
Anti Neuronal Nuclear Antibody Type 1, 2, or 3
N Type Calcium Channel Antibody
AChR Ganglionic Neuronal Antibody
Anti-Glial Nuclear Antibody, Type 1
Amphiphysin Antibody Western Blot (reflex)
Striational (Striated Muscle) Antibody
Acetylcholine Receptor Antibodies
Neuromyelitis Optica (NMO)/Aquaporin-4-IgG (reflex)
GAD65 Antibody (reflex)
GABA-B-R Antibody (reflex)
Neuronal (V-G) K Channel Antibody
CRMP-5-IgG Western Blot (reflex)
Paraneoplastic Antibody Western Blot (reflex)
ACh Receptor (Muscle) Modulating Antibody (reflex)
AMPA-R Antibody (reflex)
NMDA-R Antibody (reflex)
Paraneoplastic AutoAb Eval, S
Amphiphysin Ab Western Blot
Neuromyelitis Optica Ab IgG
Voltage-Gated Potassium Channel Antibody
Looking to order a test?
We’ve provided helpful links to make ordering easy.Find a Requisition
All specimens should be accompanied by a requisition.Submitting Specimens
Learn about how to properly label and where to ship specimens.Order Kits and Supplies
MLabs provides all the supplies necessary for the collection of specimens.Test FAQ
Visit our provider FAQ and learn about common questions to ordering tests.
Investigating a subacute multifocal neurological disorder without obvious cause, especially in a patient with past or family history of cancer, or smoking history. Directing a focused search for cancer. Investigating neurological symptoms that appear in the course or wake of cancer therapy, and are not explainable by metastasis. Differentiating autoimmune neuropathies from neurotoxic effects of chemotherapy. Monitoring the immune response of seropositive patients in the course of cancer therapy. Detecting early evidence of cancer recurrence in previously seropositive patients.
Interpretive report provided.
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
Collect blood in SST or red top tube. Centrifuge, aliquot serum into a plastic vial and refrigerate. Include relevant clinical information as well as ordering physician name, telephone number, and mailing address. Indicate if order is a follow-up for a previously diagnosed patient; the patient's previously elevated autoantibodies will be performed.